{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:59:31Z","timestamp":1773280771312,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:00:00Z","timestamp":1500076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00417-017-3727-5","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T13:37:37Z","timestamp":1500125857000},"page":"2009-2015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy"],"prefix":"10.1007","volume":"255","author":[{"given":"Hiroshi","family":"Inazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayoshi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Kadonosono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,15]]},"reference":[{"key":"3727_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"The AGIS Investigators","year":"2000","unstructured":"The AGIS Investigators (2000) The advanced glaucoma intervention study (AGIS): 7 the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429\u2013440","journal-title":"Am J Ophthalmol"},{"key":"3727_CR2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (Chicago, Ill : 1960) 120:701\u2013713 discussion 829-730","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"key":"3727_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","volume":"116","author":"DC Musch","year":"2009","unstructured":"Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK (2009) Visual field progression in the collaborative initial glaucoma treatment study the impact of treatment and other baseline factors. Ophthalmology 116:200\u2013207. doi:\n10.1016\/j.ophtha.2008.08.051","journal-title":"Ophthalmology"},{"key":"3727_CR4","first-page":"137","volume":"42","author":"M Honjo","year":"2001","unstructured":"Honjo M, Tanihara H, Inatani M, Kido N, Sawamura T, Yue BY, Narumiya S, Honda Y (2001) Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 42:137\u2013144","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3727_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3109\/02713683.2013.874444","volume":"39","author":"T Isobe","year":"2014","unstructured":"Isobe T, Mizuno K, Kaneko Y, Ohta M, Koide T, Tanabe S (2014) Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits. Curr Eye Res 39:813\u2013822. doi:\n10.3109\/02713683.2013.874444","journal-title":"Curr Eye Res"},{"key":"3727_CR6","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1167\/iovs.11-8018","volume":"53","author":"T Kameda","year":"2012","unstructured":"Kameda T, Inoue T, Inatani M, Fujimoto T, Honjo M, Kasaoka N, Inoue-Mochita M, Yoshimura N, Tanihara H (2012) The effect of rho-associated protein kinase inhibitor on monkey Schlemm\u2019s canal endothelial cells. Invest Ophthalmol Vis Sci 53:3092\u20133103. doi:\n10.1167\/iovs.11-8018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3727_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.exer.2004.08.029","volume":"80","author":"PV Rao","year":"2005","unstructured":"Rao PV, Deng P, Sasaki Y, Epstein DL (2005) Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility. Exp Eye Res 80:197\u2013206. doi:\n10.1016\/j.exer.2004.08.029","journal-title":"Exp Eye Res"},{"key":"3727_CR8","first-page":"1029","volume":"42","author":"PV Rao","year":"2001","unstructured":"Rao PV, Deng PF, Kumar J, Epstein DL (2001) Modulation of aqueous humor outflow facility by the rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci 42:1029\u20131037","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3727_CR9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archopht.116.5.633","volume":"116","author":"B Tian","year":"1998","unstructured":"Tian B, Kaufman PL, Volberg T, Gabelt BT, Geiger B (1998) H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch Ophthalmol (Chicago, Ill : 1960) 116:633\u2013643","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"key":"3727_CR10","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jamaophthalmol.2013.323","volume":"131","author":"H Tanihara","year":"2013","unstructured":"Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Araie M (2013) Phase 1 clinical trials of a selective rho kinase inhibitor, K-115. JAMA Ophthalmol 131:1288\u20131295. doi:\n10.1001\/jamaophthalmol.2013.323","journal-title":"JAMA Ophthalmol"},{"key":"3727_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ajo.2013.05.016","volume":"156","author":"H Tanihara","year":"2013","unstructured":"Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Araie M (2013) Phase 2 randomized clinical study of a rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension. Am J Ophthalmol 156:731\u2013736. doi:\n10.1016\/j.ajo.2013.05.016","journal-title":"Am J Ophthalmol"},{"key":"3727_CR12","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1111\/aos.12829","volume":"94","author":"H Tanihara","year":"2016","unstructured":"Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Fukushima A, Suganami H, Araie M (2016) One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension. Acta Ophthalmol 94:e26\u2013e34. doi:\n10.1111\/aos.12829","journal-title":"Acta Ophthalmol"},{"key":"3727_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamaophthalmol.2015.0525","volume":"133","author":"H Tanihara","year":"2015","unstructured":"Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Suganami H, Araie M (2015) Additive intraocular pressure-lowering effects of the rho kinase inhibitor Ripasudil (K-115) combined with Timolol or Latanoprost: a report of 2 randomized clinical trials. JAMA Ophthalmol 133:755\u2013761. doi:\n10.1001\/jamaophthalmol.2015.0525","journal-title":"JAMA Ophthalmol"},{"key":"3727_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/ijg.0000000000000552","volume":"26","author":"H Inazaki","year":"2017","unstructured":"Inazaki H, Kobayashi S, Anzai Y, Satoh H, Sato S, Inoue M, Yamane S, Kadonosono K (2017) Efficacy of the additional use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled under maximum medical therapy. J Glaucoma 26:96\u2013100. doi:\n10.1097\/ijg.0000000000000552","journal-title":"J Glaucoma"},{"key":"3727_CR15","unstructured":"Anderson DR, Patella VM (1999) Automated static Perimetry Mosby, St. Louis"},{"key":"3727_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2131\/fts.1.19","volume":"1","author":"KWY Omichi","year":"2014","unstructured":"Omichi KWY, Yoneyama S (2014) Nonclinical safety assessment for the sensitizing potential of K-115. Fund Toxicol Sci 1:19\u201324","journal-title":"Fund Toxicol Sci"},{"key":"3727_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/IJG.0b013e318166656d","volume":"17","author":"K Kashiwagi","year":"2008","unstructured":"Kashiwagi K, Tsumura T, Tsukahara S (2008) Long-term effects of latanoprost monotherapy on intraocular pressure in Japanese glaucoma patients. J Glaucoma 17:662\u2013666. doi:\n10.1097\/IJG.0b013e318166656d","journal-title":"J Glaucoma"},{"key":"3727_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10384-013-0284-2","volume":"58","author":"K Kashiwagi","year":"2014","unstructured":"Kashiwagi K, Furuya T (2014) Persistence with topical glaucoma therapy among newly diagnosed Japanese patients. Jpn J Ophthalmol 58:68\u201374. doi:\n10.1007\/s10384-013-0284-2","journal-title":"Jpn J Ophthalmol"},{"key":"3727_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1185\/03007991003659012","volume":"26","author":"SR Hahn","year":"2010","unstructured":"Hahn SR, Kotak S, Tan J, Kim E (2010) Physicians\u2019 treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma. Curr Med Res Opin 26:957\u2013963. doi:\n10.1185\/03007991003659012","journal-title":"Curr Med Res Opin"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-017-3727-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3727-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3727-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T08:02:39Z","timestamp":1505548959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-017-3727-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,15]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["3727"],"URL":"https:\/\/doi.org\/10.1007\/s00417-017-3727-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,15]]}}}